GI oncology Clinical Trials in Arlington, TX
As of June 2026, 1 paid clinical trial is recruiting for GI oncology in Arlington, Texas. GI oncology trials cover colorectal, pancreatic, gastric, esophageal, liver, and biliary cancers — testing chemotherapy combinations, targeted agents, and immunotherapy for microsatellite-instability-high tumors. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
1 clinical trial for GI oncology
·Clear filters·↓ Download CSVAbout research studies in Arlington
Arlington has approximately 63 recruiting research studies across a wide range of therapeutic areas. Texas hosts major cancer and cardiovascular research centers including MD Anderson Cancer Center, Baylor College of Medicine, UT Southwestern Medical Center, and the Texas Medical Center — the largest medical complex in the world.
Top Research Study Locations in Arlington
Researchers run research studies in Arlington, TX at 40 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Texas at Arlington | Quality of Life, Aging, Alcohol Abstinence | 7 |
| Texas Clinical Research Institute, LLC | Liver Cirrhosis, Liver Fibrosis, Metabolic Dysfunction Associated Steatohepatitis | 4 |
| Arlington Research Center, Inc | Hidradenitis Suppurativa, Alopecia Areata, Atopic Dermatitis | 4 |
| Arlington Nephrology | FSGS, Proteinuric Kidney Disease, Autosomal Dominant Polycystic Kidney Disease | 3 |
| Rheumatology Associates | Scleroderma, Systemic Sclerosis (SSc), Radiographic Axial Spondyloarthritis | 3 |
| Texas Oncology - DFW | Advanced Non-Small Cell Lung Cancer, Breast Cancer, Breast Neoplasms | 2 |
| Arlington Center for Dermatology | Chronic Spontaneous Urticaria (CSU), Plaque Psoriasis | 2 |
| Arlington Research Center | Dermatitis Atopic | 2 |
| UPNT Research Institute, LLC | High-Risk Non-Muscle-Invasive Bladder Cancer, Upper Urinary Tract Urothelial Carcinoma, Urothelial Carcinoma | 2 |
| University of Texas Arlington | Aging, Peripheral Artery Disease (PAD) | 2 |
| Urology Partners of North Texas | Erectile Dysfunction (ED), Non-muscle Invasive Bladder Cancer | 2 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, NASH - Nonalcoholic Steatohepatitis | 1 |
| Arlington | Endometriosis, Uterine Fibroids | 1 |
| Arlington Nephrology, PLLC. | Diabetic Kidney Disease (DKD) | 1 |
| Arlington Research Center, Inc. | Hidradenitis Suppurativa | 1 |
| Artiva Investigational | IIM, Idiopathic Inflammatory Myopathies (IIMs), Myositis | 1 |
| Dallas Renal Group - Mansfield | Proteinuric Kidney Disease | 1 |
| Enveda Investigative Site | Atopic Dermatitis (AD) | 1 |
| GSK Investigational Site | Liver Diseases, Alcoholic | 1 |
| Galderma Investigational | Systemic Sclerosis | 1 |
| Hs0006 50201 | Hidradenitis Suppurativa | 1 |
| Investigative Site | CLE, Cutaneous Lupus Erythematosus (CLE), SLE | 1 |
| Investigator | Focal Segmental Glomerulosclerosis | 1 |
| Local Institution - 007-879-A | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Local Institution - 007-879-B | Advanced Non-Small Cell Lung Cancer, Metastatic Non-Small Cell Lung Cancer | 1 |
| Novartis Investigative Site | Atopic Dermatitis | 1 |
| Ps0021 50201 | Moderate to Severe Plaque Psoriasis | 1 |
| TX Onc - Arlington North | Endometrial Cancer, Recurrent or Progressive Endometrial Cancer | 1 |
| Texas Clinical Research Institute | Primary Biliary Cholangitis (PBC) | 1 |
| Texas Health Research & Education Institute | AV Block, Heart Failure, Heart Failure With Reduced Ejection Fraction | 1 |
| Texas Oncology Arlington North | Gastric Adenocarcinoma, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma | 1 |
| Texas Oncology Dallas Fort Worth West (DFWW) - Arlington Cancer Center North | Untreated, Unresectable, or Metastatic Colorectal Cancer | 1 |
| Texas Retina Associates | Neovascular Age-Related Macular Degeneration | 1 |
| The Center for Cancer and Blood Disorders | Metastatic Castration-resistant Prostate Cancer | 1 |
| UPNT Research Institute | Incontinence, Urinary, Overactive Bladder, Urge Incontinence | 1 |
| UTArlington | Symptoms of Depression | 1 |
| University of Texas at Arlington Movement & Physical Activity Epidemiology Laboratory | Adult ALL | 1 |
| Urology Partner of North Texas | Benign Prostatic Hyperplasia, Home Monitoring, Lower Urinary Tract Dysfunction | 1 |
| Urology Partners of North Texas (UPNT) | Benign Prostatic Hyperplasia, Overactive Bladder, Prostate Cancer | 1 |
Active & Upcoming Studies in Arlington (2026)
Recruiting trials in Arlington grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (11 active studies)
- Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer · Phase 3 · Pfizer
- A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer · Phase 2, Phase 3 · Bristol-Myers Squibb
Cardiovascular (4 active studies)
- A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. · Phase 2 · AstraZeneca
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease · Phase 3 · Alnylam Pharmaceuticals
Mental health & behavior (2 active studies)
- Exploring Virtual Reality Adventure Training Exergaming · The University of Texas at Arlington
- Effects of Exercise and Virtual Reality on Depression · The University of Texas at Arlington
Diabetes & metabolic (1 active study)
- A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH · Phase 3 · Akero Therapeutics, Inc
Neurology & pain (1 active study)
- Asthma Intervention With Residential Ventilation and Air Cleaner (AIRVAC) Study · The University of Texas at Arlington
Eye & vision (1 active study)
- Extension Study for the Port Delivery System With Ranibizumab (Portal) · Phase 3 · Hoffmann-La Roche
Common conditions studied in Arlington
- Atopic Dermatitis (3 active studies). Atopic dermatitis studies test IL-13 inhibitors, JAK inhibitors, and next-generation topical therapies for moderate-to-severe eczema.
- Hidradenitis Suppurativa (3 active studies). Recruiting Hidradenitis Suppurativa studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Advanced Non-Small Cell Lung Cancer (2 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
- Aging (2 active studies). Recruiting Aging studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Benign Prostatic Hyperplasia (2 active studies). Recruiting Benign Prostatic Hyperplasia studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Chronic Kidney Disease and Hypertension (2 active studies). Hypertension research tests new antihypertensive drug classes, renal denervation devices, and fixed-dose combinations for resistant disease.
Leading research sponsors in Arlington
- The University of Texas at Arlington
- AbbVie
- Boehringer Ingelheim
- AstraZeneca
- Bristol-Myers Squibb
Local regulations and guidelines
Clinical trials in Texas are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials run in Texas must also comply with the Texas Medical Privacy Act (TMPA), which extends federal HIPAA protections to a broader range of entities handling participant data.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Arlington. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Arlington
Hipa.ai aggregates every recruiting study in Arlington from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Arlington?
There are approximately 63 recruiting clinical trials in Arlington, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Arlington pay participants?
Most recruiting trials in Arlington compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Arlington?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Arlington?
The most common conditions under active study in Arlington include Atopic Dermatitis (3), Hidradenitis Suppurativa (3), Advanced Non-Small Cell Lung Cancer (2), Aging (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Arlington?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Arlington on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Arlington?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Arlington?
Recruiting research sites in Arlington include University of Texas at Arlington, Texas Clinical Research Institute, LLC, Arlington Research Center, Inc, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Arlington right now?
The largest active categories in Arlington are Cancer & tumors (11), Cardiovascular (4), Mental health & behavior (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.